157 related articles for article (PubMed ID: 37775560)
1. mTORC1-selective activation of translation elongation promotes disease progression in chronic lymphocytic leukemia.
Malik N; Hay J; Almuhanna HNB; Dunn KM; Lees J; Cassels J; Li J; Nakagawa R; Sansom OJ; Michie AM
Leukemia; 2023 Dec; 37(12):2414-2425. PubMed ID: 37775560
[TBL] [Abstract][Full Text] [Related]
2. PEITC-mediated inhibition of mRNA translation is associated with both inhibition of mTORC1 and increased eIF2α phosphorylation in established cell lines and primary human leukemia cells.
Yeomans A; Lemm E; Wilmore S; Cavell BE; Valle-Argos B; Krysov S; Hidalgo MS; Leonard E; Willis AE; Forconi F; Stevenson FK; Steele AJ; Coldwell MJ; Packham G
Oncotarget; 2016 Nov; 7(46):74807-74819. PubMed ID: 27579538
[TBL] [Abstract][Full Text] [Related]
3. Genetic removal of eIF2α kinase PERK in mice enables hippocampal L-LTP independent of mTORC1 activity.
Zimmermann HR; Yang W; Beckelman BC; Kasica NP; Zhou X; Galli LD; Ryazanov AG; Ma T
J Neurochem; 2018 Jul; 146(2):133-144. PubMed ID: 29337352
[TBL] [Abstract][Full Text] [Related]
4. Direct and indirect activation of eukaryotic elongation factor 2 kinase by AMP-activated protein kinase.
Johanns M; Pyr Dit Ruys S; Houddane A; Vertommen D; Herinckx G; Hue L; Proud CG; Rider MH
Cell Signal; 2017 Aug; 36():212-221. PubMed ID: 28502587
[TBL] [Abstract][Full Text] [Related]
5. mTORC1 activity is essential for erythropoiesis and B cell lineage commitment.
Malik N; Dunn KM; Cassels J; Hay J; Estell C; Sansom OJ; Michie AM
Sci Rep; 2019 Nov; 9(1):16917. PubMed ID: 31729420
[TBL] [Abstract][Full Text] [Related]
6. A decrease in eukaryotic elongation factor 2 phosphorylation is required for local translation of sensorin and long-term facilitation in Aplysia.
McCamphill PK; Ferguson L; Sossin WS
J Neurochem; 2017 Jul; 142(2):246-259. PubMed ID: 28345161
[TBL] [Abstract][Full Text] [Related]
7. Targeting mTORC1-mediated metabolic addiction overcomes fludarabine resistance in malignant B cells.
Sharma A; Janocha AJ; Hill BT; Smith MR; Erzurum SC; Almasan A
Mol Cancer Res; 2014 Sep; 12(9):1205-15. PubMed ID: 25061101
[TBL] [Abstract][Full Text] [Related]
8. RAPTOR promotes colorectal cancer proliferation by inducing mTORC1 and upregulating ribosome assembly factor URB1.
Wang T; Zhang WS; Wang ZX; Wu ZW; Du BB; Li LY; Chen YF; Yang XF; Hao XY; Guo TK
Cancer Med; 2020 Feb; 9(4):1529-1543. PubMed ID: 31886628
[TBL] [Abstract][Full Text] [Related]
9. mTORC1/2 Inhibitor Served as a More Ideal Agent Against the Growth of Mouse Lymphocytic Leukemia Both
Liao HF; Lin YZ; Yu CC; Tai TS; Hung SK; Yang CC; Su YC
Anticancer Res; 2019 Sep; 39(9):4829-4835. PubMed ID: 31519585
[TBL] [Abstract][Full Text] [Related]
10. Rapamycin-induced G1 arrest in cycling B-CLL cells is associated with reduced expression of cyclin D3, cyclin E, cyclin A, and survivin.
Decker T; Hipp S; Ringshausen I; Bogner C; Oelsner M; Schneller F; Peschel C
Blood; 2003 Jan; 101(1):278-85. PubMed ID: 12393642
[TBL] [Abstract][Full Text] [Related]
11. Loss of mTOR complex 1 induces developmental blockage in early T-lymphopoiesis and eradicates T-cell acute lymphoblastic leukemia cells.
Hoshii T; Kasada A; Hatakeyama T; Ohtani M; Tadokoro Y; Naka K; Ikenoue T; Ikawa T; Kawamoto H; Fehling HJ; Araki K; Yamamura K; Matsuda S; Hirao A
Proc Natl Acad Sci U S A; 2014 Mar; 111(10):3805-10. PubMed ID: 24567410
[TBL] [Abstract][Full Text] [Related]
12. Selective interference of mTORC1/RAPTOR protects against human disc cellular apoptosis, senescence, and extracellular matrix catabolism with Akt and autophagy induction.
Ito M; Yurube T; Kakutani K; Maeno K; Takada T; Terashima Y; Kakiuchi Y; Takeoka Y; Miyazaki S; Kuroda R; Nishida K
Osteoarthritis Cartilage; 2017 Dec; 25(12):2134-2146. PubMed ID: 28888905
[TBL] [Abstract][Full Text] [Related]
13. Rapamycin administration in humans blocks the contraction-induced increase in skeletal muscle protein synthesis.
Drummond MJ; Fry CS; Glynn EL; Dreyer HC; Dhanani S; Timmerman KL; Volpi E; Rasmussen BB
J Physiol; 2009 Apr; 587(Pt 7):1535-46. PubMed ID: 19188252
[TBL] [Abstract][Full Text] [Related]
14. Dual targeting of androgen receptor and mTORC1 by salinomycin in prostate cancer.
Mirkheshti N; Park S; Jiang S; Cropper J; Werner SL; Song CS; Chatterjee B
Oncotarget; 2016 Sep; 7(38):62240-62254. PubMed ID: 27557496
[TBL] [Abstract][Full Text] [Related]
15. Bicuculline regulated protein synthesis is dependent on Homer1 and promotes its interaction with eEF2K through mTORC1-dependent phosphorylation.
Gladulich LFH; Xie J; Jensen KB; Kamei M; Paes-de-Carvalho R; Cossenza M; Proud CG
J Neurochem; 2021 May; 157(4):1086-1101. PubMed ID: 32892352
[TBL] [Abstract][Full Text] [Related]
16. Phosphorylation of eukaryotic elongation factor 2 (eEF2) by cyclin A-cyclin-dependent kinase 2 regulates its inhibition by eEF2 kinase.
Hizli AA; Chi Y; Swanger J; Carter JH; Liao Y; Welcker M; Ryazanov AG; Clurman BE
Mol Cell Biol; 2013 Feb; 33(3):596-604. PubMed ID: 23184662
[TBL] [Abstract][Full Text] [Related]
17. Leucine stimulates protein synthesis in skeletal muscle of neonatal pigs by enhancing mTORC1 activation.
Suryawan A; Jeyapalan AS; Orellana RA; Wilson FA; Nguyen HV; Davis TA
Am J Physiol Endocrinol Metab; 2008 Oct; 295(4):E868-75. PubMed ID: 18682538
[TBL] [Abstract][Full Text] [Related]
18. microRNA-181a downregulates deptor for TGFβ-induced glomerular mesangial cell hypertrophy and matrix protein expression.
Maity S; Bera A; Ghosh-Choudhury N; Das F; Kasinath BS; Choudhury GG
Exp Cell Res; 2018 Mar; 364(1):5-15. PubMed ID: 29397070
[TBL] [Abstract][Full Text] [Related]
19. 1-Benzyl-3-cetyl-2-methylimidazolium iodide (NH125) induces phosphorylation of eukaryotic elongation factor-2 (eEF2): a cautionary note on the anticancer mechanism of an eEF2 kinase inhibitor.
Chen Z; Gopalakrishnan SM; Bui MH; Soni NB; Warrior U; Johnson EF; Donnelly JB; Glaser KB
J Biol Chem; 2011 Dec; 286(51):43951-43958. PubMed ID: 22020937
[TBL] [Abstract][Full Text] [Related]
20. NF-κB-p62-NRF2 survival signaling is associated with high ROR1 expression in chronic lymphocytic leukemia.
Sanchez-Lopez E; Ghia EM; Antonucci L; Sharma N; Rassenti LZ; Xu J; Sun B; Kipps TJ; Karin M
Cell Death Differ; 2020 Jul; 27(7):2206-2216. PubMed ID: 31992855
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
